Business Wire

PTW Announces Business Acquisition of LA-Based Art Powerhouse, 5518 Studios

11.2.2021 17:00:00 EET | Business Wire | Press release

Share

PTW continues on their mission to be the go-to partner for innovation in the games industry with the business acquisition of premier art studio 5518 Studios. The industry-leading video games and tech services outsourcer announced their business acquisition of Los Angeles-based 5518 Studios; PTW is a long-time industry leader with an established and diverse dossier of top-tier clients and nearly 3 decades of experience in the games industry. PTW’s work spans across all platforms and all genres.

5518’s expertise ranges from high-quality concept & illustration art to character modeling & animation, along with everything in-between; PTW’s expansion ensures a greater range of skills, depth of talent, and overall expertise for their partners across the globe. Today’s announcement is an exciting step forward in PTW’s mission to provide full end-to-end co-development services to partners in the growing global games industry.

“Our mission is to revolutionize the digital entertainment sphere; adding 5518 to our team enables us to be one of the top development studios in the world. We will merge our existing game development brand- Orange Rock Studios- with 5518 under one name; our new brand will be perfectly poised to work alongside top-notch developers and publishers, building the best games & digital experiences around the world,” said Kasturi Rangan, Chief Product Officer of PTW. “When it comes to game development, we will now be a one-stop shop for external partnerships,” Rangan concluded.

PTW will be merging both Orange Rock and 5518 under a new name- 1518 Studios. The new brand will have a much stronger offering encompassing art, end-end game development, live ops, porting, product development, and staff augmentation (across Mobile, PC & Console). Michael Casalino, CEO and Co-founder of 5518 Studios added, “Our values and mission align so well with those of PTW; we each believe in strong relationships built on trust, passion, good communication, and high-quality games services.” 5518 COO and CO-founder Maxim Miheyenko concluded, “We are so excited to join the PTW family of brands.”

PTW CEO Deborah Kirkham concluded, “We are happy to welcome 5518 Studios and our new teams in Los Angeles, St. Petersburg, and Moscow to the PTW family. Expanding our global presence in the games industry is an important step in our mission of providing the best talent and the best technology to our partners around the world. Michael, Maxim, and their teams provide a level of expertise and energy which we can’t wait to bring to our partners.”

About PTW

PTW is a leading games, digital entertainment and interactive media solutions provider with 35 offices in 11 countries worldwide. Our range of services include quality assurance, localization, customer experience, engineering and development services, and audio production services. PTW brings nearly 3 decades of experience and the infrastructure to create customized support for projects and clients of all sizes.

PTW, comprised of global subsidiaries, is a UK-based holding company formed in 2016 under the umbrella of Poletowin Pitcrew Holdings, Inc. which is listed on the 1st Section of Tokyo Stock Exchange as 3657. POLE TO WIN is a registered trademark of Pole To Win Co., Ltd. in Japan and other countries. All rights reserved. For more information, visit https://www.ptw.com/

The PTW group includes SIDE, 1518 Studios, Entalize, The Game Dev Show, and OR Esports.

Stay connected with PTW on Facebook, Twitter and LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For queries related to PTW, please email:
Media Contacts:
Kaley Hurst
415-521-8709
Kaley.hurst@ptw.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 08:00:00 EEST | Press release

Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob

EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 04:45:00 EEST | Press release

EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia

Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release

Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye